First-Ever Genomic Test Predicts Which Lung Cancer Patients Need Chemotherapy To Live

Duke University Medical Center scientists have developed the first-ever genomic test to predict which patients with early-stage lung cancer will need chemotherapy to live and which patients can avoid the toxic regimen of drugs.

>>> Discuss This Story

Back to news